Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 Jul 26;11:659200. doi: 10.3389/fonc.2021.659200

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2021 Zhu, Xie, Yu, Yao, Xu, Huang, Wu, Li, Zheng, Liu, Xie, Huang, Li, Zheng, Zhang, Qiao, Chan and Zhou

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

PMC Copyright notice

Survival analyses in the OAK/POPLAR cohorts. (A) Kaplan–Meier curves of overall survival (OS) in the patients with KEAP1/NFE2L2 mutations who received atezolizumab and docetaxel in the OAK/POPLAR cohorts. (B) Kaplan–Meier curves of OS in the patients without KEAP1/NFE2L2 mutations who received atezolizumab and docetaxel in the OAK/POPLAR cohorts. (C) Kaplan–Meier curves of OS in the patients with KEAP1/NFE2L2 mutations who received atezolizumab and docetaxel in the OAK cohort. (D) Kaplan–Meier curves of OS in the patients without KEAP1/NFE2L2 mutations who received atezolizumab and docetaxel in the OAK cohort. (E) Kaplan–Meier curves of OS in the patients with KEAP1/NFE2L2 mutations who received atezolizumab and docetaxel in the POPLAR cohort. (F) Kaplan–Meier curves of the OS in the patients without KEAP1/NFE2L2 mutations who received atezolizumab and docetaxel in the POPLAR cohort.